Ovalbumin-containing core-shell implants suitable to obtain a delayed IgG1 antibody response in support of a biphasic pulsatile release profile in mice.

A single-injection vaccine formulation that provides for both a prime and a boost immunization would have various advantages over a multiple-injection regime. For such a vaccine formulation, it is essential that the booster dose is released after a certain, preferably adjustable, lag time. In this s...

Full description

Bibliographic Details
Main Authors: Katie Amssoms, Philip A Born, Max Beugeling, Ben De Clerck, Ellen Van Gulck, Wouter L J Hinrichs, Henderik W Frijlink, Niels Grasmeijer, Guenter Kraus, Roger Sutmuller, Kenny Simmen, Lieven Baert
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC6117011?pdf=render
_version_ 1819072936199323648
author Katie Amssoms
Philip A Born
Max Beugeling
Ben De Clerck
Ellen Van Gulck
Wouter L J Hinrichs
Henderik W Frijlink
Niels Grasmeijer
Guenter Kraus
Roger Sutmuller
Kenny Simmen
Lieven Baert
author_facet Katie Amssoms
Philip A Born
Max Beugeling
Ben De Clerck
Ellen Van Gulck
Wouter L J Hinrichs
Henderik W Frijlink
Niels Grasmeijer
Guenter Kraus
Roger Sutmuller
Kenny Simmen
Lieven Baert
author_sort Katie Amssoms
collection DOAJ
description A single-injection vaccine formulation that provides for both a prime and a boost immunization would have various advantages over a multiple-injection regime. For such a vaccine formulation, it is essential that the booster dose is released after a certain, preferably adjustable, lag time. In this study we investigated whether a core-shell based implant, containing ovalbumin as core material and poly(DL-lactic-co-glycolic acid) of various monomer ratios as shell material can be used to obtain such a booster release. An in vitro release study showed that the lag time after which the ovalbumin was released from the core-shell implant increased with increasing lactic to glycolic acid ratio of the polymer and ranged from 3-6 weeks. Fluorescence spectroscopy showed minimal differences between native ovalbumin and ovalbumin from core-shell implants that were incubated until just before the observed in vitro release. In addition, mice immunized with a subcutaneous inserted core-shell implant containing ovalbumin showed an ovalbumin-specific IgG1 antibody response after a lag time of 4 or 6-8 weeks. Moreover, delayed release of ovalbumin caused higher IgG1 antibody titers than conventional subcutaneous vaccination with ovalbumin dissolved in PBS. Collectively, these findings could contribute to the further development of a single-injection vaccine, making multiple injections of the vaccine superfluous.
first_indexed 2024-12-21T17:45:38Z
format Article
id doaj.art-39d9cf7d09974343b19898981fbcf509
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-21T17:45:38Z
publishDate 2018-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-39d9cf7d09974343b19898981fbcf5092022-12-21T18:55:30ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01138e020296110.1371/journal.pone.0202961Ovalbumin-containing core-shell implants suitable to obtain a delayed IgG1 antibody response in support of a biphasic pulsatile release profile in mice.Katie AmssomsPhilip A BornMax BeugelingBen De ClerckEllen Van GulckWouter L J HinrichsHenderik W FrijlinkNiels GrasmeijerGuenter KrausRoger SutmullerKenny SimmenLieven BaertA single-injection vaccine formulation that provides for both a prime and a boost immunization would have various advantages over a multiple-injection regime. For such a vaccine formulation, it is essential that the booster dose is released after a certain, preferably adjustable, lag time. In this study we investigated whether a core-shell based implant, containing ovalbumin as core material and poly(DL-lactic-co-glycolic acid) of various monomer ratios as shell material can be used to obtain such a booster release. An in vitro release study showed that the lag time after which the ovalbumin was released from the core-shell implant increased with increasing lactic to glycolic acid ratio of the polymer and ranged from 3-6 weeks. Fluorescence spectroscopy showed minimal differences between native ovalbumin and ovalbumin from core-shell implants that were incubated until just before the observed in vitro release. In addition, mice immunized with a subcutaneous inserted core-shell implant containing ovalbumin showed an ovalbumin-specific IgG1 antibody response after a lag time of 4 or 6-8 weeks. Moreover, delayed release of ovalbumin caused higher IgG1 antibody titers than conventional subcutaneous vaccination with ovalbumin dissolved in PBS. Collectively, these findings could contribute to the further development of a single-injection vaccine, making multiple injections of the vaccine superfluous.http://europepmc.org/articles/PMC6117011?pdf=render
spellingShingle Katie Amssoms
Philip A Born
Max Beugeling
Ben De Clerck
Ellen Van Gulck
Wouter L J Hinrichs
Henderik W Frijlink
Niels Grasmeijer
Guenter Kraus
Roger Sutmuller
Kenny Simmen
Lieven Baert
Ovalbumin-containing core-shell implants suitable to obtain a delayed IgG1 antibody response in support of a biphasic pulsatile release profile in mice.
PLoS ONE
title Ovalbumin-containing core-shell implants suitable to obtain a delayed IgG1 antibody response in support of a biphasic pulsatile release profile in mice.
title_full Ovalbumin-containing core-shell implants suitable to obtain a delayed IgG1 antibody response in support of a biphasic pulsatile release profile in mice.
title_fullStr Ovalbumin-containing core-shell implants suitable to obtain a delayed IgG1 antibody response in support of a biphasic pulsatile release profile in mice.
title_full_unstemmed Ovalbumin-containing core-shell implants suitable to obtain a delayed IgG1 antibody response in support of a biphasic pulsatile release profile in mice.
title_short Ovalbumin-containing core-shell implants suitable to obtain a delayed IgG1 antibody response in support of a biphasic pulsatile release profile in mice.
title_sort ovalbumin containing core shell implants suitable to obtain a delayed igg1 antibody response in support of a biphasic pulsatile release profile in mice
url http://europepmc.org/articles/PMC6117011?pdf=render
work_keys_str_mv AT katieamssoms ovalbumincontainingcoreshellimplantssuitabletoobtainadelayedigg1antibodyresponseinsupportofabiphasicpulsatilereleaseprofileinmice
AT philipaborn ovalbumincontainingcoreshellimplantssuitabletoobtainadelayedigg1antibodyresponseinsupportofabiphasicpulsatilereleaseprofileinmice
AT maxbeugeling ovalbumincontainingcoreshellimplantssuitabletoobtainadelayedigg1antibodyresponseinsupportofabiphasicpulsatilereleaseprofileinmice
AT bendeclerck ovalbumincontainingcoreshellimplantssuitabletoobtainadelayedigg1antibodyresponseinsupportofabiphasicpulsatilereleaseprofileinmice
AT ellenvangulck ovalbumincontainingcoreshellimplantssuitabletoobtainadelayedigg1antibodyresponseinsupportofabiphasicpulsatilereleaseprofileinmice
AT wouterljhinrichs ovalbumincontainingcoreshellimplantssuitabletoobtainadelayedigg1antibodyresponseinsupportofabiphasicpulsatilereleaseprofileinmice
AT henderikwfrijlink ovalbumincontainingcoreshellimplantssuitabletoobtainadelayedigg1antibodyresponseinsupportofabiphasicpulsatilereleaseprofileinmice
AT nielsgrasmeijer ovalbumincontainingcoreshellimplantssuitabletoobtainadelayedigg1antibodyresponseinsupportofabiphasicpulsatilereleaseprofileinmice
AT guenterkraus ovalbumincontainingcoreshellimplantssuitabletoobtainadelayedigg1antibodyresponseinsupportofabiphasicpulsatilereleaseprofileinmice
AT rogersutmuller ovalbumincontainingcoreshellimplantssuitabletoobtainadelayedigg1antibodyresponseinsupportofabiphasicpulsatilereleaseprofileinmice
AT kennysimmen ovalbumincontainingcoreshellimplantssuitabletoobtainadelayedigg1antibodyresponseinsupportofabiphasicpulsatilereleaseprofileinmice
AT lievenbaert ovalbumincontainingcoreshellimplantssuitabletoobtainadelayedigg1antibodyresponseinsupportofabiphasicpulsatilereleaseprofileinmice